Since CD38 and ZAP70 are important prognostic markers of CLL, we divided patients into the following groups (using a 20 % cutoff value for CD38 and ZAP70): CD38+ and CD38−, and ZAP70+ and ZAP70−. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.